Literature DB >> 29484844

The BPSC: A prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and benign prostatic hyperplasia in Chinese population.

Xian-Tao Zeng1, Tong-Zu Liu1, Kan Gong2, Da-Lin He3, Xing-Huan Wang1.   

Abstract

Bladder cancer and benign prostatic hyperplasia have been two very common diseases among the elderly men, especially with the aging of the population in the world. We have designed a study to investigate the clinical effect of interventional therapy for plasmakinetic resection of the prostate and plasmakinetic resection of the bladder, which is called "BPSC" (The bladder cancer and benign prostatic hyperplasia study in Chinese population). The BPSC is not only a specific study, it is made up of many studies. In this article, we introduced the research background, source, name, study framework, study management and further direction of BPSC project. We hope this process will contribute to the growth of the database through sharing data and enriching the evidence of bladder cancer and benign prostatic hyperplasia in the Chinese population, thereby finally improving the accessibility of these important findings for doctors, researchers, and patients.
© 2018 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  BPSC; benign prostatic hyperplasia; bladder cancer; evidence-based medicine; plasmakinetic resection of the bladder; plasmakinetic resection of the prostate; risk factor

Mesh:

Year:  2018        PMID: 29484844     DOI: 10.1111/jebm.12290

Source DB:  PubMed          Journal:  J Evid Based Med        ISSN: 1756-5391


  9 in total

1.  Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study.

Authors:  Cong Zhu; Lan Yang; Hao Zi; Bing-Hui Li; Qiao Huang; Meng-Xin Lu; Xiao-Dong Li; Xuan-Yi Ren; Hua Tao; Hankun Hu; Xian-Tao Zeng
Journal:  Biomed Res Int       Date:  2022-06-22       Impact factor: 3.246

2.  Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients.

Authors:  Xian-Tao Zeng; Hong Weng; Jing Xiong; Qiao Huang; Lin-Lu Ma; Ying-Hui Jin; Xing-Huan Wang
Journal:  Front Physiol       Date:  2018-09-24       Impact factor: 4.566

3.  Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients.

Authors:  Bing-Hui Li; Tong Deng; Qiao Huang; Hao Zi; Hong Weng; Xian-Tao Zeng
Journal:  Am J Mens Health       Date:  2019 Jul-Aug

4.  Fasting blood glucose level and hypertension risk in aging benign prostatic hyperplasia patients.

Authors:  Hao Zi; Xue-Jun Wang; Ming-Juan Zhao; Qiao Huang; Xing-Huan Wang; Xian-Tao Zeng
Journal:  Aging (Albany NY)       Date:  2019-07-03       Impact factor: 5.682

5.  Analysis of the relationship between asthma and benign prostatic hyperplasia: A STROBE-compliant study.

Authors:  Jee Hye Wee; Woo Jin Bang; Min Woo Park; Soo-Hwan Byun; Hyo Geun Choi
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

6.  Can Routine Blood and Urine Parameters Reveal Clues to Detect Bladder Cancer? A Case-Control Study.

Authors:  Dan-Qi Wang; Juan Shuai; Hang Zheng; Zhong-Qiang Guo; Qiao Huang; Xiao-Feng Xu; Xiao-Dong Li; Hao Zi; Dao-Jing Ming; Xuan-Yi Ren; Xian-Tao Zeng
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

7.  Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition).

Authors:  Xian-Tao Zeng; Ying-Hui Jin; Tong-Zu Liu; Fang-Ming Chen; De-Gang Ding; Meng Fu; Xin-Quan Gu; Bang-Min Han; Xing Huang; Zhi Hou; Wan-Li Hu; Xin-Li Kang; Gong-Hui Li; Jian-Xing Li; Pei-Jun Li; Chao-Zhao Liang; Xiu-Heng Liu; Zhi-Yu Liu; Chun-Xiao Liu; Jiu-Min Liu; Guang-Heng Luo; Yi Luo; Wei-Jun Qin; Jian-Hong Qiu; Jian-Xin Qiu; Xue-Jun Shang; Ben-Kang Shi; Fa Sun; Guo-Xiang Tian; Ye Tian; Feng Wang; Feng Wang; Yin-Huai Wang; Yu-Jie Wang; Zhi-Ping Wang; Zhong Wang; Qiang Wei; Min-Hui Xiao; Wan-Hai Xu; Fa-Xian Yi; Chao-Yang Zhu; Qian-Yuan Zhuang; Li-Qun Zhou; Xiao-Feng Zou; Nian-Zeng Xing; Da-Lin He; Xing-Huan Wang
Journal:  Mil Med Res       Date:  2022-04-01

8.  Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study.

Authors:  Shuo Fang; Yuchen Liu; Huiru Dai; Tianshun Gao; Leli Zeng; Rui Sun; Zilong Zheng; Jinqiu Yuan; Bin Xia; Yihang Pan
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

9.  Association between Diabetes Mellitus and Hypertension in Benign Prostatic Hyperplasia Patients.

Authors:  Xian-Tao Zeng; Hong Weng; Ying-Hui Jin; Tong-Zu Liu; Mei-Yan Liu; Xing-Huan Wang
Journal:  Chin Med J (Engl)       Date:  2018-05-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.